NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress

  • Written by ACN Newswire

image

SHELTON, CT / ACCESSWIRE, Feb 24, 2020 - (ACN Newswire) - NanoViricides, Inc. (NYSE American: NNVC), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, has filed its quarterly report for its second quarter of financial year 2020 in a timely manner with the Securities and Exchange...

Read more: NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash,...